Rapid Whole Genome Sequencing Versus Conventional Culture for Optimizing Antibiotic Therapy in Perforation Peritonitis: A Prospective Observational Study
This prospective observational study demonstrates that rapid whole genome sequencing outperforms conventional culture in diagnosing perforation peritonitis by offering superior pathogen detection, identifying more polymicrobial infections, and significantly reducing turnaround time, thereby enabling earlier antibiotic optimization and improved surgical outcomes in a high-resistance setting.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When the wall of the intestine ruptures, the body faces a silent, internal crisis. The sterile space inside the belly, which should be free of germs, suddenly fills with digestive fluids and the bacteria that live within the gut. This condition, known as perforation peritonitis, triggers a violent immune response that can quickly spiral into sepsis, where the body's own defenses begin to damage its organs. To survive, a patient needs surgery to repair the hole and antibiotics to kill the invading bacteria. However, the bacteria involved are rarely just one type; they are a chaotic mix of many different species, some aerobic and some that thrive without oxygen. The biggest hurdle for doctors is time. The standard way to identify these germs involves growing them in a lab, a process that takes days. During that wait, doctors must guess which antibiotics will work, often choosing broad-spectrum drugs that kill many types of bacteria but also encourage the rise of superbugs that resist treatment. In a race against a spreading infection, those few days of uncertainty can be the difference between life and death.
In a prospective study conducted at a teaching hospital in Uttar Pradesh, India, researchers set out to test a new way to win that race. They compared the traditional method of growing bacteria in a lab against a modern technique called rapid whole genome sequencing. This new method does not wait for bacteria to grow; instead, it reads the genetic code of every organism present in a fluid sample directly from the patient. The study followed seventy patients who had undergone surgery for a perforated intestine. For each patient, the surgeons collected fluid from the belly and split it into two samples. One sample went to the standard lab for culture, while the other went to a sequencer to have its genetic material read. The goal was to see which method could identify the bacteria faster and more accurately, and whether that speed helped doctors choose the right medicine sooner.
The results showed a clear advantage for the genetic approach. The sequencing method identified the specific bacteria in every single patient, whereas the traditional culture method missed the infection entirely in nearly eighteen percent of the cases. This gap was even wider when looking at complex infections involving multiple types of bacteria. The sequencing tool found a mix of different germs in almost seventy percent of the patients, while the culture method only spotted the mix in about half of them. In many cases, the culture test suggested only one type of bacteria was present, but the genetic test revealed a hidden second or third invader. The speed difference was equally striking. The genetic test provided a full report, including the species-level identification of the bacteria and the detection of antimicrobial resistance genes, in an average of thirty-three hours. The traditional culture method took more than three days, averaging seventy-seven hours, to deliver similar information.
This delay had real consequences for the patients. When the researchers looked back at the treatment plans, they found that fewer than forty percent of the patients had received the correct antibiotic from the very start. Because the doctors were working without a confirmed diagnosis, they often had to change the medication later. In fact, nearly two-thirds of the patients required a switch in their antibiotic regimen once the sequencing results arrived, and every single one of those changes involved an escalation of therapy. The study also linked these diagnostic delays to physical outcomes. Patients who developed infections at the surgical site were almost exclusively those who had a complex mix of bacteria that the initial tests failed to catch. Furthermore, patients who did not receive the right antibiotic immediately were far more likely to develop these surgical site infections. While the overall death rate in the group was sixteen percent, those who went into septic shock faced a much higher risk of dying.
The study concludes that reading the genetic code of the infection offers a significant improvement over waiting for bacteria to grow in a dish. It provides a complete picture of the microbial threat much faster, allowing doctors to target the specific germs present rather than guessing. In a setting where antibiotic resistance is a growing problem, this speed allows for more precise treatment, potentially reducing the need for broad-spectrum drugs and improving the chances of recovery. The researchers suggest that bringing this technology into routine hospital workflows could help manage these life-threatening emergencies more effectively, particularly in regions where the burden of resistant bacteria is high.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.